Author

J. Gotlib

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. C. Trotman-Grant· 1 shared A. Krishnan· 1 shared C. Garcia· 1 shared C. V. Neste· 1 shared G. Wernig· 1 shared H. Maecker· 1 shared I. Moraga· 1 shared I. S. Hitchcock· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. C. Trotman-Grant

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Enkurin: A novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens.

M. S. Sumanth, Y. Liu, J. Wu, L. Fechter, K. Murugesan, H. Maecker, J. Gotlib, J. Zehnder, R. Paulmurugan, A. Krishnan

The paper identifies enkurin as a novel marker of myeloproliferative neoplasms (MPNs) through analysis of platelet, megakaryocyte, and whole blood specimens, showing inverse association with CDC20 and involvement of calcium homeostasis and ER stress.

bioRxiv · Jan 7, 2023Cancer Biology

Tuning TPO-R signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia

L. Cui, I. Moraga, T. Lerbs, C. V. Neste, S. Wilmes, N. Tsutsumi, A. C. Trotman-Grant, M. Gakovic, S. Andrews, J. Gotlib, S. Darmanis, M. Enge, S. Quake, I. S. Hitchcock, J. Piehler, , G. Wernig

This study develops diabody ligands that modulate TPO-R signaling, showing partial agonists preserve HSCs and inhibit ET oncogenesis.

bioRxiv · Sep 23, 2020Cell Biology